TREM2 and nonpapillary renal cell carcinoma: Using VIPER in a non-metastatic, treatment-naïve surgical cohort of ccRCC patients, our group also recently uncovered a novel TAM subpopulation undetectable by gene expression analysis alone that is characterized by upregulation of TREM2/APOE/C1Q37.